Sign In
Buy BXC
$51.13
-1.39 (-2.65%)
At Close: Jun 03, 2026
BlueLinx Holdings Inc. (BXC) CEO Mitchell Lewis on Q1 2020 Results - Earnings Call Transcript
04:54pm, Saturday, 09'th May 2020
BlueLinx Holdings Inc. (NYSE:BXC) Q1 2020 Earnings Conference Call May 06, 2020 10:00 AM ET Company Participants Mary Moll - Director of Investor Relations Mitc
BlueLinx Holdings (BXC) Reports Q1 Loss, Misses Revenue Estimates
12:45am, Wednesday, 06'th May 2020
BlueLinx (BXC) delivered earnings and revenue surprises of 78.95% and -0.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
BlueLinx Holdings (BXC) Reports Q1 Loss, Misses Revenue Estimates
12:00am, Wednesday, 06'th May 2020
Stocks Analysis by Zacks Investment Research covering: S&P 500. Read Zacks Investment Research's latest article on Investing.com
BlueLinx Hldgs Q1 EPS $(0.080) Beats $(0.380) Estimate, Sales $662.000M Miss $662.400M Estimate
08:49pm, Tuesday, 05'th May 2020BlueLinx Announces 2020 First Quarter Financial Results
08:40pm, Tuesday, 05'th May 2020
MARIETTA, Ga., May 05, 2020 -- BlueLinx Holdings Inc. (NYSE:BXC), a leading distributor of building and industrial products in the United States, today reported financial.
LP Reports First Quarter 2020 Results, Announces Quarterly Dividend, and Discusses Liquidity and COVID-19 Pandemic Response
12:00am, Tuesday, 05'th May 2020
LP today reported its financial results for the quarter ended March 31, 2020 and provided an update on liquidity and COVID-19 pandemic response.
Patent Filings Roundup: ‘Something in the Water’ with Sharp Spike in District Court Filings
04:15pm, Wednesday, 29'th Apr 2020
While Patent Trial and Appeal Board filings were up slightly this week, the district courts—particularly the Texas branches—had a banner week, with 127 new patent filings—54 of which were filed
82 Biggest Movers From Yesterday
08:30am, Wednesday, 29'th Apr 2020
Gainers
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) shares climbed 69.4% to close at $19.50 on Tuesday after the company presented positive preclinical and initial clinical data...
BlueLinx Says Received Notice From NYSE Indicating Co. Is Not In Compliance With Listing Standards
08:37pm, Tuesday, 28'th Apr 2020BlueLinx NYSE Listing Standards Announcement
08:30pm, Tuesday, 28'th Apr 2020
BlueLinx Holdings Inc. (BXC), a leading distributor of building and industrial products in the United States, today announced that it received written notice from the New York Stock Exchange (NYSE) th
Analysts Estimate BlueLinx Holdings (BXC) to Report a Decline in Earnings: What to Look Out for
12:00am, Tuesday, 28'th Apr 202010 Biggest Price Target Changes For Thursday
12:13pm, Thursday, 09'th Apr 2020
Stephens & Co. reduced Caterpillar Inc. (NYSE: CAT) price target from $100 to $80. Caterpillar shares closed at $127.40 on Wednesday.
Evercore ISI Group lowered the price...
86 Biggest Movers From Yesterday
09:43am, Thursday, 09'th Apr 2020
Gainers
Moleculin Biotech Inc (NASDAQ: MBRX) shares jumped 125.7% to close at $1.27 on Wednesday after it said that independent research found 2-deoxy-D-glucose (2-DG)to reduce...
B. Riley Downgrades BlueLinx Hldgs to Neutral, Lowers Price Target to $6
09:12am, Thursday, 09'th Apr 202065 Stocks Moving In Wednesday's Mid-Day Session
04:35pm, Wednesday, 08'th Apr 2020
Gainers
Moleculin Biotech Inc (NASDAQ: MBRX) shares climbed 174% to $1.54 after it said that independent research found 2-deoxy-D-glucose (2-DG)to reduce replication of...
